Anti-tumor necrosis factor-alpha treatment reduces allergic responses in an allergic rhinitis mouse model

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 2, 2011, Pages 279-286

  Mo, J H ^a   Kang, E K ^b   Quan, S H ^b   Rhee, C S ^b   Lee, C H ^b   Kim, Dong Young ^b  

^a Dankook University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

allergic rhinitis; cell adhesion molecules; IgE; infliximab; tumor necrosis factor

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN E; INFLIXIMAB; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC REACTION; ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EXPERIMENTAL STUDY; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; TH2 CELL;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTIBODIES, MONOCLONAL; CELL ADHESION MOLECULES; CYTOKINES; EOSINOPHILS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MICE; MICE, INBRED BALB C; NASAL MUCOSA; OVALBUMIN; RHINITIS; TH2 CELLS;

EID: 78651082556     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02476.x     Document Type: Article

References (18)

1. Artis D, Humphreys NE, Bancroft AJ, Rothwell NJ, Potten CS, Grencis RK,. Tumor necrosis factor alpha is a critical component of interleukin 13-mediated protective T helper cell type 2 responses during helminth infection. J Exp Med 1999; 190: 953-962.
2. Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K,. Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med 1997; 186: 1737-1747.
3. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP,. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 2008; 117: 244-279.
4. Siddiqui MA, Scott LJ,. Infliximab: a review of its use in Crohn's disease and rheumatoid arthritis. Drugs 2005; 65: 2179-2208.
5. Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH, et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006; 354: 697-708.
6. Erin EM, Leaker BR, Nicholson GC, Tan AJ, Green LM, Neighbour H, et al. The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med 2006; 174: 753-762.
7. Morjaria JB, Chauhan AJ, Babu KS, Polosa R, Davies DE, Holgate ST,. The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial. Thorax 2008; 63: 584-591.
8. Deveci F, Muz MH, Ilhan N, Kirkil G, Turgut T, Akpolat N,. Evaluation of the anti-inflammatory effect of infliximab in a mouse model of acute asthma. Respirology 2008; 13: 488-497.
9. Kim J, McKinley L, Natarajan S, Bolgos GL, Siddiqui J, Copeland S, et al. Anti-tumor necrosis factor-alpha antibody treatment reduces pulmonary inflammation and methacholine hyper-responsiveness in a murine asthma model induced by house dust. Clin Exp Allergy 2006; 36: 122-132.
10. Iwasaki M, Saito K, Takemura M, Sekikawa K, Fujii H, Yamada Y, et al. TNF-alpha contributes to the development of allergic rhinitis in mice. J Allergy Clin Immunol 2003; 112: 134-140.
11. Broide DH, Stachnick G, Castaneda D, Nayar J, Sriramarao P,. Inhibition of eosinophilic inflammation in allergen-challenged TNF receptor p55/p75 - and TNF receptor p55-deficient mice. Am J Respir Cell Mol Biol 2001; 24: 304-311.
12. Rudmann DG, Moore MW, Tepper JS, Aldrich MC, Pfeiffer JW, Hogenesch H, et al., Modulation of allergic inflammation in mice deficient in TNF receptors. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1047-L1057.
13. Kanehiro A, Lahn M, Makela MJ, Dakhama A, Fujita M, Joetham A, et al. Tumor necrosis factor-alpha negatively regulates airway hyperresponsiveness through gamma-delta T cells. Am J Respir Crit Care Med 2001; 164: 2229-2238.
14. Kavanaugh A, St Clair EW, McCune WJ, Braakman T, Lipsky P,. Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy. J Rheumatol 2000; 27: 841-850.
15. Del Prete G, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988; 140: 4193-4198.
16. Ueda A, Chandswang N, Ovary Z,. The action of interleukin-4 on antigen-specific IgG1 and IgE production by interaction of in vivo primed B cells and carrier-specific cloned Th2 cells. Cell Immunol 1990; 128: 31-40.
17. Li MO, Flavell RA,. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 2008; 28: 468-476.
18. Bevilacqua MP,. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993; 11: 767-804.